A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
FORMULATION CHARACTERIZATION AND IN VITRO EVALUATION OF PULSATILE DRUG DELIVERY OF MONTELUKAST SODIUM
2022
Zenodo
The Montelukast pulsatile delivery system was created with the goal of delivering the drug to the colon for successful treatment of nocturnal asthma. The microspheres were sealed within the insoluble hard gelatin capsule body with an erodible hydrogel plug to create a time delayed capsule. Emulsion solvent evaporation was used to make the microspheres. Based on dissolving tests, optimised microsphere formulations were designed. The entire device was enteric coated in order to overcome the
doi:10.5281/zenodo.6570400
fatcat:afkvmie6o5gtrpegpxiqq2uwne